4//SEC Filing
Zhang Xiaoyan Michelle 4
Accession 0000899243-21-048230
CIK 0001835579other
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 8:48 PM ET
Size
8.5 KB
Accession
0000899243-21-048230
Insider Transaction Report
Form 4
Zhang Xiaoyan Michelle
Chief Scientific Officer
Transactions
- Sale
Common Stock
2021-12-10$14.76/sh−1,000$14,760→ 44,475 total - Exercise/Conversion
Common Stock
2021-12-10$2.15/sh+1,000$2,146→ 45,475 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-12-10−1,000→ 25,473 totalExercise: $2.15Exp: 2028-12-17→ Common Stock (1,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to this option vested and became exercisable on December 14, 2018, with the remainder vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Ikena Oncology, Inc.
CIK 0001835579
Entity typeother
Related Parties
1- filerCIK 0001895321
Filing Metadata
- Form type
- 4
- Filed
- Dec 13, 7:00 PM ET
- Accepted
- Dec 14, 8:48 PM ET
- Size
- 8.5 KB